author-photo

Mary Jane Cullen

Bristol-Myers Squibb

9

Papers

238

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists

2017 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (10)
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setup

2015 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (5)
Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (8)
Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (11)
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties.

2013 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (7)
Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet‐Induced Obese (DIO) Rats

2012 Obesity
Show All
- Source
- Cite
- Save
Citations (138)
Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (19)
Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series.

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (36)